CAPN considers advocacy part of the professional responsibility of its members. Current initiatives concern medication access and formulary fairness for paediatric nephrology patients. If there is an issue CAPN should be speaking about, from a patient or a health care provider perspective, write to contact@capneph.ca.
-
Medication access is not equitable for Canadian children
CAPN’s opinion editorial on inequity in children’s access to medications in Canada, with references.
-
Improving paediatric medications: a prescription for Canadian children and youth
A white paper on paediatric medication equity, developed with paediatric stakeholders including CAPN.
-
Cystinosis: access to treatment in Canada
Access to Cystagon and Procysbi, the Special Access Program criteria, and CAPN’s advocacy on the issue.
-
Statement from CAPN on racism
Issued by the executive in June 2020.
-
Industry relationship policy
How CAPN and its members engage with industry.